Whetstone Capital Advisors’s Health Catalyst HCAT Stock Holding History

Whetstone Capital Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$333K	Sell	167,097 -4,101,044	-96%	-$5.92M	0.09%	42
2026 Q1	$5.42M	Buy	4,268,141 +517,764	+14%	+$974K	1.88%	14
2025 Q4	$8.96M	Buy	3,750,377 +19,027	+0.5%	+$52K	2.8%	10
2025 Q3	$10.6M	Hold	3,731,350	–	–	2.94%	10
2025 Q2	$14.1M	Buy	3,731,350 +2,026,278	+119%	+$7.97M	3.97%	8
2025 Q1	$7.72M	Buy	+1,705,072	New	+$9.02M	3.41%	10

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Whetstone Capital Advisors's HCAT Position: Q2 2026 in Review

Whetstone Capital Advisors reduced its Health Catalyst (HCAT) stake by 96% in Q2 2026, selling an estimated $5.92M and leaving 167,097 shares worth $333K. The position accounts for 0.09% of the portfolio, ranked #42.

Whetstone Capital Advisors first reported a position in HCAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.1M in Q2 2025. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Whetstone Capital Advisors held 167,097 shares of Health Catalyst worth $333K as of Q2 2026.
Whetstone Capital Advisors sold 4,101,044 Health Catalyst shares in Q2 2026, an estimated $5.92M.
Health Catalyst made up 0.09% of Whetstone Capital Advisors's portfolio in Q2 2026, its #42 holding.
Whetstone Capital Advisors first reported a position in Health Catalyst in Q1 2025 and has held it in 6 quarters since.
Whetstone Capital Advisors's Health Catalyst position peaked at $14.1M in Q2 2025.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Whetstone Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.